The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Apomorphine Hydrochloride Market Research Report 2025
Synopsis
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The global Apomorphine Hydrochloride market was valued at US$ 277.7 million in 2023 and is anticipated to reach US$ 364.1 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report aims to provide a comprehensive presentation of the global market for Apomorphine Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apomorphine Hydrochloride.
Report Scope
The Apomorphine Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Apomorphine Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Apomorphine Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
Segment by Type
Injection
Tablets
Thinfilm
Nasal Powder (Pipeline)
Segment by Application
Parkinson Disease
Erectile Dysfunction
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Apomorphine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The global Apomorphine Hydrochloride market was valued at US$ 277.7 million in 2023 and is anticipated to reach US$ 364.1 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report aims to provide a comprehensive presentation of the global market for Apomorphine Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apomorphine Hydrochloride.
Report Scope
The Apomorphine Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Apomorphine Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Apomorphine Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
Segment by Type
Injection
Tablets
Thinfilm
Nasal Powder (Pipeline)
Segment by Application
Parkinson Disease
Erectile Dysfunction
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Apomorphine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Apomorphine Hydrochloride Market Overview
1.1 Product Overview and Scope of Apomorphine Hydrochloride
1.2 Apomorphine Hydrochloride Segment by Type
1.2.1 Global Apomorphine Hydrochloride Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Tablets
1.2.4 Thinfilm
1.2.5 Nasal Powder (Pipeline)
1.3 Apomorphine Hydrochloride Segment by Application
1.3.1 Global Apomorphine Hydrochloride Market Value by Application: (2024-2030)
1.3.2 Parkinson Disease
1.3.3 Erectile Dysfunction
1.4 Global Apomorphine Hydrochloride Market Size Estimates and Forecasts
1.4.1 Global Apomorphine Hydrochloride Revenue 2019-2030
1.4.2 Global Apomorphine Hydrochloride Sales 2019-2030
1.4.3 Global Apomorphine Hydrochloride Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Apomorphine Hydrochloride Market Competition by Manufacturers
2.1 Global Apomorphine Hydrochloride Sales Market Share by Manufacturers (2019-2024)
2.2 Global Apomorphine Hydrochloride Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Apomorphine Hydrochloride Average Price by Manufacturers (2019-2024)
2.4 Global Apomorphine Hydrochloride Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Apomorphine Hydrochloride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Apomorphine Hydrochloride, Product Type & Application
2.7 Apomorphine Hydrochloride Market Competitive Situation and Trends
2.7.1 Apomorphine Hydrochloride Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Apomorphine Hydrochloride Players Market Share by Revenue
2.7.3 Global Apomorphine Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Apomorphine Hydrochloride Retrospective Market Scenario by Region
3.1 Global Apomorphine Hydrochloride Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Apomorphine Hydrochloride Global Apomorphine Hydrochloride Sales by Region: 2019-2030
3.2.1 Global Apomorphine Hydrochloride Sales by Region: 2019-2024
3.2.2 Global Apomorphine Hydrochloride Sales by Region: 2025-2030
3.3 Global Apomorphine Hydrochloride Global Apomorphine Hydrochloride Revenue by Region: 2019-2030
3.3.1 Global Apomorphine Hydrochloride Revenue by Region: 2019-2024
3.3.2 Global Apomorphine Hydrochloride Revenue by Region: 2025-2030
3.4 North America Apomorphine Hydrochloride Market Facts & Figures by Country
3.4.1 North America Apomorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Apomorphine Hydrochloride Sales by Country (2019-2030)
3.4.3 North America Apomorphine Hydrochloride Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Apomorphine Hydrochloride Market Facts & Figures by Country
3.5.1 Europe Apomorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Apomorphine Hydrochloride Sales by Country (2019-2030)
3.5.3 Europe Apomorphine Hydrochloride Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Apomorphine Hydrochloride Market Facts & Figures by Country
3.6.1 Asia Pacific Apomorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Apomorphine Hydrochloride Sales by Country (2019-2030)
3.6.3 Asia Pacific Apomorphine Hydrochloride Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Apomorphine Hydrochloride Market Facts & Figures by Country
3.7.1 Latin America Apomorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Apomorphine Hydrochloride Sales by Country (2019-2030)
3.7.3 Latin America Apomorphine Hydrochloride Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Apomorphine Hydrochloride Market Facts & Figures by Country
3.8.1 Middle East and Africa Apomorphine Hydrochloride Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Apomorphine Hydrochloride Sales by Country (2019-2030)
3.8.3 Middle East and Africa Apomorphine Hydrochloride Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Apomorphine Hydrochloride Sales by Type (2019-2030)
4.1.1 Global Apomorphine Hydrochloride Sales by Type (2019-2024)
4.1.2 Global Apomorphine Hydrochloride Sales by Type (2025-2030)
4.1.3 Global Apomorphine Hydrochloride Sales Market Share by Type (2019-2030)
4.2 Global Apomorphine Hydrochloride Revenue by Type (2019-2030)
4.2.1 Global Apomorphine Hydrochloride Revenue by Type (2019-2024)
4.2.2 Global Apomorphine Hydrochloride Revenue by Type (2025-2030)
4.2.3 Global Apomorphine Hydrochloride Revenue Market Share by Type (2019-2030)
4.3 Global Apomorphine Hydrochloride Price by Type (2019-2030)
5 Segment by Application
5.1 Global Apomorphine Hydrochloride Sales by Application (2019-2030)
5.1.1 Global Apomorphine Hydrochloride Sales by Application (2019-2024)
5.1.2 Global Apomorphine Hydrochloride Sales by Application (2025-2030)
5.1.3 Global Apomorphine Hydrochloride Sales Market Share by Application (2019-2030)
5.2 Global Apomorphine Hydrochloride Revenue by Application (2019-2030)
5.2.1 Global Apomorphine Hydrochloride Revenue by Application (2019-2024)
5.2.2 Global Apomorphine Hydrochloride Revenue by Application (2025-2030)
5.2.3 Global Apomorphine Hydrochloride Revenue Market Share by Application (2019-2030)
5.3 Global Apomorphine Hydrochloride Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Supernus Pharmaceuticals
6.1.1 Supernus Pharmaceuticals Corporation Information
6.1.2 Supernus Pharmaceuticals Description and Business Overview
6.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolio
6.1.5 Supernus Pharmaceuticals Recent Developments/Updates
6.2 Britannia Pharmaceuticals STADA
6.2.1 Britannia Pharmaceuticals STADA Corporation Information
6.2.2 Britannia Pharmaceuticals STADA Description and Business Overview
6.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolio
6.2.5 Britannia Pharmaceuticals STADA Recent Developments/Updates
6.3 Ever Pharma
6.3.1 Ever Pharma Corporation Information
6.3.2 Ever Pharma Description and Business Overview
6.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ever Pharma Apomorphine Hydrochloride Product Portfolio
6.3.5 Ever Pharma Recent Developments/Updates
6.4 Evolan Pharma AB (PharmSwed)
6.4.1 Evolan Pharma AB (PharmSwed) Corporation Information
6.4.2 Evolan Pharma AB (PharmSwed) Description and Business Overview
6.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolio
6.4.5 Evolan Pharma AB (PharmSwed) Recent Developments/Updates
6.5 Tianjin Tianwei Pharmaceutical
6.5.1 Tianjin Tianwei Pharmaceutical Corporation Information
6.5.2 Tianjin Tianwei Pharmaceutical Description and Business Overview
6.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolio
6.5.5 Tianjin Tianwei Pharmaceutical Recent Developments/Updates
6.6 Sunovion
6.6.1 Sunovion Corporation Information
6.6.2 Sunovion Description and Business Overview
6.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sunovion Apomorphine Hydrochloride Product Portfolio
6.6.5 Sunovion Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Apomorphine Hydrochloride Industry Chain Analysis
7.2 Apomorphine Hydrochloride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Apomorphine Hydrochloride Production Mode & Process
7.4 Apomorphine Hydrochloride Sales and Marketing
7.4.1 Apomorphine Hydrochloride Sales Channels
7.4.2 Apomorphine Hydrochloride Distributors
7.5 Apomorphine Hydrochloride Customers
8 Apomorphine Hydrochloride Market Dynamics
8.1 Apomorphine Hydrochloride Industry Trends
8.2 Apomorphine Hydrochloride Market Drivers
8.3 Apomorphine Hydrochloride Market Challenges
8.4 Apomorphine Hydrochloride Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
